How much is the Systemic Mastocytosis Treatment Market market?

The systemic mastocytosis treatment market market size is estimated to grow at $157.1 million in 2023. Read More

What is the growth rate of the Systemic Mastocytosis Treatment Market market?

The growth rate of the systemic mastocytosis treatment market year-over-year is 6.2%. Read More

Which region held the largest market share in the Systemic Mastocytosis Treatment Market market?

North America is the region to held the largest market share with 41.9% growth. Read More

Who are the key players in the Systemic Mastocytosis Treatment Market market?

A. Menarini Industrie Farmaceutiche Riunite Srl, AB Science SA, AdvaCare Pharma, BDR Pharmaceuticals Internationals Pvt. Ltd, Blueprint Medicines Corp., Dr Reddys Laboratories Ltd., F. Hoffmann .... Read More

Which Segment has the largest market share in the Systemic Mastocytosis Treatment Market market?

Type is the segment that has the largest market share in the market. Read More

Systemic Mastocytosis Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, UK, France, Spain, Canada, Japan, South Korea, India - Size and Forecast 2024-2028

Published: Oct 2024
Pages: 209
SKU: IRTNTR80230

Enjoy complimentary customisation on priority with our Enterprise License!

Systemic Mastocytosis Treatment Market Size 2024-2028

The systemic mastocytosis treatment market size is forecast to increase by USD 157.1 million at a CAGR of 6.2% between 2023 and 2028.

The market is experiencing significant growth due to the increasing aging population and advancements in diagnostic technologies. With an aging population comes a higher prevalence of age-related diseases, including systemic mastocytosis. This condition, characterized by the overproduction of mast cells, can lead to various symptoms and complications, necessitating effective treatment. Advancements in diagnostic technologies have facilitated earlier detection and diagnosis of systemic mastocytosis, enabling timely intervention and management. However, the high cost associated with these treatments poses a significant challenge for both patients and healthcare systems. Despite this hurdle, the market presents numerous opportunities for companies that can offer cost-effective and innovative solutions.
To capitalize on these opportunities, companies must stay abreast of the latest diagnostic and therapeutic advancements, while also addressing the affordability issue. Collaborations with healthcare providers and insurers, as well as the exploration of alternative treatment modalities, can help mitigate the financial burden on patients and improve market penetration. By focusing on these strategic initiatives, companies can effectively navigate the challenges and seize the growth opportunities in the market.

What will be the Size of the Systemic Mastocytosis Treatment Market during the forecast period?

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2023

4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global Systemic Mastocytosis Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2018 - 2022 ($ million)

5.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)

5.3 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)

5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global Systemic Mastocytosis Treatment Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)

8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

8.3 AK-002 - Market size and forecast 2023-2028
- Chart on AK-002 - Market size and forecast 2023-2028 ($ million)
- Data Table on AK-002 - Market size and forecast 2023-2028 ($ million)
- Chart on AK-002 - Year-over-year growth 2023-2028 (%)
- Data Table on AK-002 - Year-over-year growth 2023-2028 (%)

8.4 BLU-285 - Market size and forecast 2023-2028
- Chart on BLU-285 - Market size and forecast 2023-2028 ($ million)
- Data Table on BLU-285 - Market size and forecast 2023-2028 ($ million)
- Chart on BLU-285 - Year-over-year growth 2023-2028 (%)
- Data Table on BLU-285 - Year-over-year growth 2023-2028 (%)

8.5 Brentuximab vedotin - Market size and forecast 2023-2028
- Chart on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
- Data Table on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
- Chart on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
- Data Table on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)

8.6 Crenolanib besylate - Market size and forecast 2023-2028
- Chart on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
- Data Table on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
- Chart on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
- Data Table on Crenolanib besylate - Year-over-year growth 2023-2028 (%)

8.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Route of Administration

9.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)

9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration

9.3 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)

9.4 Injectables - Market size and forecast 2023-2028
- Chart on Injectables - Market size and forecast 2023-2028 ($ million)
- Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
- Chart on Injectables - Year-over-year growth 2023-2028 (%)
- Data Table on Injectables - Year-over-year growth 2023-2028 (%)

9.5 Topical - Market size and forecast 2023-2028
- Chart on Topical - Market size and forecast 2023-2028 ($ million)
- Data Table on Topical - Market size and forecast 2023-2028 ($ million)
- Chart on Topical - Year-over-year growth 2023-2028 (%)
- Data Table on Topical - Year-over-year growth 2023-2028 (%)

9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

11.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)

11.12 Spain - Market size and forecast 2023-2028
- Chart on Spain - Market size and forecast 2023-2028 ($ million)
- Data Table on Spain - Market size and forecast 2023-2028 ($ million)
- Chart on Spain - Year-over-year growth 2023-2028 (%)
- Data Table on Spain - Year-over-year growth 2023-2028 (%)

11.13 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

11.14 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)

11.15 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)

11.16 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)

11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers

12.2 Market challenges

12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview

13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

13.3 Landscape disruption
- Overview on factors of disruption

13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered

14.2 Company ranking index
- Company ranking index

14.3 Market positioning of companies
- Matrix on companies position and classification

14.4 A. Menarini Industrie Farmaceutiche Riunite Srl
- A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
- A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
- A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
- SWOT

14.5 Blueprint Medicines Corp.
- Blueprint Medicines Corp. - Overview
- Blueprint Medicines Corp. - Product / Service
- Blueprint Medicines Corp. - Key news
- Blueprint Medicines Corp. - Key offerings
- SWOT

14.6 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT

14.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT

14.8 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT

14.9 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT

14.10 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT

14.11 NOVA PHARMA LLC
- NOVA PHARMA LLC - Overview
- NOVA PHARMA LLC - Product / Service
- NOVA PHARMA LLC - Key offerings
- SWOT

14.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT

14.13 Ono Pharmaceutical Co. Ltd.
- Ono Pharmaceutical Co. Ltd. - Overview
- Ono Pharmaceutical Co. Ltd. - Product / Service
- Ono Pharmaceutical Co. Ltd. - Key offerings
- SWOT

14.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT

14.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT

14.16 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT

14.17 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

14.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report

15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist

15.3 Currency conversion rates for US$
- Currency conversion rates for US$

15.4 Research methodology
- Research methodology

15.5 Data procurement
- Information sources

15.6 Data validation
- Data validation

15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing

15.8 Data synthesis
- Data synthesis

15.9 360 degree market analysis
- 360 degree market analysis

15.10 List of abbreviations
- List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES